A global approach to long‐term follow‐up of targeted and immune‐based therapy in childhood and adolescence
- 16 April 2021
- journal article
- editorial
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 68 (7) , e29047
Abstract
While considerable efforts and progress in our understanding of the long‐term toxicities of surgery, radiation and chemotherapy in children with cancer have been made over the last 5 decades, there continues to be a wide gap in our knowledge of the long‐term health impact of most novel targeted and immunotherapy agents. To address this gap, ACCELERATE, a multi‐stakeholder collaboration of clinical and translational academics, regulators from the EMA and FDA, patient/family advocates and members spanning small biotechnology through to large pharmaceutical companies have initiated the development of an international long‐term follow‐up data registry to collect this important information prospectively. Providing critical safety data on the long‐term use of these approved and investigational therapies in children will support the regulatory requirements and labeling information. It will also provide the necessary insight to help guide physicians and families on the appropriateness of a targeted or immune therapy for their child and inform survivorship planning.Keywords
This publication has 8 references indexed in Scilit:
- Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912)Clinical Cancer Research, 2021
- Annual report to the nation on the status of cancer, part I: National cancer statisticsCancer, 2020
- ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patientsEuropean Journal of Cancer, 2020
- A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory BRAF V600 Mutation–Positive Solid TumorsClinical Cancer Research, 2019
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic LeukemiaNew England Journal of Medicine, 2018
- Pediatric oncology enters an era of precision medicineCurrent Problems in Cancer, 2017
- Survivorship after childhood cancer: PanCare: A European Network to promote optimal long-term careEuropean Journal of Cancer, 2015
- Pediatric Cancer Survivorship Research: Experience of the Childhood Cancer Survivor StudyJournal of Clinical Oncology, 2009